TWST Twist Bioscience Corp

Price (delayed)

$15.71

Market cap

$893.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.84

Enterprise value

$670.54M

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights

TWST's gross profit has surged by 66% year-on-year and by 12% since the previous quarter

TWST's revenue is up by 48% YoY and by 6% from the previous quarter

TWST's quick ratio is up by 38% year-on-year but it is down by 4.2% since the previous quarter

Twist Bioscience's equity has increased by 19% YoY but it has decreased by 5% QoQ

The net income fell by 30% YoY

Twist Bioscience's debt has increased by 29% YoY

Sector: Healthcare

Industry: Diagnostics & Research

Website: https://www.twistbioscience.com/

Peers: MRVI MGTX NBIX

Key stats

What are the main financial stats of TWST

Market

Shares outstanding

56.86M

Market cap

$893.24M

Enterprise value

$670.54M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

1.19

Price to sales (P/S)

4.11

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.11

Earnings

Revenue

$215.79M

EBIT

-$214M

EBITDA

-$176.14M

Free cash flow

-$232.7M

Per share

EPS

-$3.84

Free cash flow per share

-$4.12

Book value per share

$13.19

Revenue per share

$3.82

TBVPS

$13.57

Balance sheet

Total assets

$909.97M

Total liabilities

$163.65M

Debt

$93.98M

Equity

$746.33M

Working capital

$458.02M

Liquidity

Debt to equity

0.13

Current ratio

6.46

Quick ratio

5.76

Net debt/EBITDA

1.26

Margins

EBITDA margin

-81.6%

Gross margin

43.6%

Net margin

-99.2%

Operating margin

-103.6%

Efficiency

Return on assets

-22.1%

Return on equity

-26.6%

Return on invested capital

-47.5%

Return on capital employed

-25.9%

Return on sales

-99.2%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

TWST stock price

How has the Twist Bioscience stock price performed over time

Intraday

-0.7%

1 week

-6.38%

1 month

-21.88%

1 year

-66.56%

YTD

-34.02%

QTD

-34.02%

Financial performance

How have Twist Bioscience's revenue and profit performed over time

Revenue

$215.79M

Gross profit

$94.07M

Operating income

-$223.47M

Net income

-$214.12M

Gross margin

43.6%

Net margin

-99.2%

TWST's gross profit has surged by 66% year-on-year and by 12% since the previous quarter

TWST's revenue is up by 48% YoY and by 6% from the previous quarter

The net income fell by 30% YoY

Twist Bioscience's operating income has decreased by 27% YoY but it has increased by 4.8% from the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation

P/E

N/A

P/B

1.19

P/S

4.11

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.11

TWST's EPS is down by 15% year-on-year but it is up by 5% since the previous quarter

TWST's P/B is 80% below its 5-year quarterly average of 6.0 and 50% below its last 4 quarters average of 2.4

Twist Bioscience's equity has increased by 19% YoY but it has decreased by 5% QoQ

TWST's P/S is 83% below its 5-year quarterly average of 25.0 and 61% below its last 4 quarters average of 10.6

TWST's revenue is up by 48% YoY and by 6% from the previous quarter

Efficiency

How efficient is Twist Bioscience business performance

Twist Bioscience's ROIC has increased by 25% YoY and by 7% from the previous quarter

TWST's return on sales is up by 18% year-on-year and by 12% since the previous quarter

The return on equity is up by 5% since the previous quarter

The ROA has increased by 4.7% from the previous quarter and by 3.1% YoY

Dividends

What is TWST's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time

TWST's quick ratio is up by 38% year-on-year but it is down by 4.2% since the previous quarter

The current ratio has grown by 34% YoY

Twist Bioscience's debt is 87% less than its equity

Twist Bioscience's debt has increased by 29% YoY

Twist Bioscience's equity has increased by 19% YoY but it has decreased by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.